Context Therapeutics (CNTX)
NASDAQ:CNTX
Holding CNTX?
Track your performance easily

Context Therapeutics (CNTX) Financial Statements

70 Followers

Context Therapeutics Financial Overview

Context Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.062; its P/E ratio is -1.84; Context Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.09M$ -3.82M$ -6.93M$ -6.17M$ -5.30M
EBITDA$ -3.09M$ -3.82M$ -6.93M-$ -5.28M
Net Income Common Stockholders$ -2.25M$ -3.67M$ -6.77M$ -5.87M$ -5.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 101.50M$ 10.10M$ 14.40M$ 21.70M$ 25.10M
Total Assets$ 102.71M$ 11.05M$ 16.06M$ 22.99M$ 27.72M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 7.97K
Net Debt$ -101.50M$ -10.10M$ -14.40M$ -21.70M$ -25.09M
Total Liabilities$ 1.60M$ 2.61M$ 4.19M$ 4.60M$ 3.76M
Stockholders Equity$ 101.08M$ 8.44M$ 11.87M$ 18.38M$ 24.01M
Cash Flow-
Free Cash Flow$ -3.36M$ -4.36M$ -7.23M-$ -4.63M
Operating Cash Flow$ -3.36M$ -4.36M$ -7.23M$ -3.46M$ -4.63M
Investing Cash Flow-----
Financing Cash Flow$ 94.80M----
Currency in USD

Context Therapeutics Earnings and Revenue History

Context Therapeutics Debt to Assets

Context Therapeutics Cash Flow

Context Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis